These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 14977297)

  • 41. Surveys of transmitted HIV drug resistance in 7 geographic Regions in China, 2008-2009.
    Liao L; Xing H; Dong Y; Qin G; Ma Y; Lu H; Chen L; Zhang L; Osborne C; Seguy N; Wei D; Sun F; Yang J; Ruan Y; Shao Y
    Clin Infect Dis; 2012 May; 54 Suppl 4():S320-3. PubMed ID: 22544196
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lower prevalence of drug resistance mutations at first-line virological failure to first-line therapy with atripla vs. tenofovir + emtricitabine/lamivudine + efavirenz administered on a multiple tablet therapy.
    Blanco JL; Montaner JS; Marconi VC; Santoro MM; Campos-Loza AE; Shafer RW; Miller MD; Paredes R; Harrigan R; Nguyen ML; Perno CF; Gonzalez-Hernandez LA; Gatell JM
    AIDS; 2014 Nov; 28(17):2531-9. PubMed ID: 25574957
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antiretroviral drug resistance and HIV-1 subtypes among treatment-naive prisoners in Kelantan, Malaysia.
    Ariffin TA; Mohamad S; Yusuf WN; Shueb RH
    J Infect Dev Ctries; 2014 Aug; 8(8):1063-7. PubMed ID: 25116676
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Emerging resistance profiles of newly approved antiretroviral drugs.
    Daar ES
    Top HIV Med; 2008; 16(4):110-6. PubMed ID: 18838744
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Three-year outcome data of second-line antiretroviral therapy in Ugandan adults: good virological response but high rate of toxicity.
    Castelnuovo B; John L; Lutwama F; Ronald A; Spacek LA; Bates M; Kamya MR; Colebunders R
    J Int Assoc Physicians AIDS Care (Chic); 2009; 8(1):52-9. PubMed ID: 19095630
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of an affordable HIV-1 virological failure assay and antiretroviral drug resistance genotyping protocol.
    Bronze M; Aitken SC; Wallis CL; Steegen K; Stuyver LJ; de Wit TF; Stevens W
    J Virol Methods; 2013 Dec; 194(1-2):300-7. PubMed ID: 23994150
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antiretroviral drug resistance among antiretroviral-naive individuals with HIV infection of unknown duration in Thailand.
    Apisarnthanarak A; Mundy LM
    Clin Infect Dis; 2008 May; 46(10):1630-1. PubMed ID: 18419506
    [No Abstract]   [Full Text] [Related]  

  • 48. Use of peripheral blood DNA for genotype antiretroviral resistance testing in drug-naive HIV-infected subjects.
    Vicenti I; Razzolini F; Saladini F; Romano L; Zazzi M
    Clin Infect Dis; 2007 Jun; 44(12):1657-61. PubMed ID: 17516412
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Viro-immunological response and emergence of resistance in HIV-infected women receiving combination antiretroviral regimens for the prevention of mother-to-child transmission in Malawi.
    Palombi L; Galluzzo CM; Pirillo MF; Liotta G; Andreotti M; Jere H; Sagno JB; Luhanga R; Mancinelli S; Ceffa S; Amici R; Marazzi MC; Vella S; Giuliano M
    J Antimicrob Chemother; 2014 Mar; 69(3):749-52. PubMed ID: 24135952
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Loss of lamivudine resistance in a zidovudine and lamivudine dual-resistant HIV-1 isolate after discontinuation of in vitro lamivudine drug pressure.
    Rusconi S; De Pasquale MP; Milazzo L; Kurtagic S; Bulgheroni E; Citterio P; Galazzi M; La Seta Catamancio S; Galli M
    Antivir Ther; 1998; 3(4):203-7. PubMed ID: 10682139
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens.
    Havlir DV; Hellmann NS; Petropoulos CJ; Whitcomb JM; Collier AC; Hirsch MS; Tebas P; Sommadossi JP; Richman DD
    JAMA; 2000 Jan; 283(2):229-34. PubMed ID: 10634339
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combating antiretroviral resistance.
    Jordan W
    J Natl Med Assoc; 2004 Feb; 96(2 Suppl):31S-32S. PubMed ID: 14977297
    [No Abstract]   [Full Text] [Related]  

  • 53. HIV resistance testing. A clinical tool.
    Paul SM; Jorden VS
    N J Med; 2003 Sep; 100(9 Suppl):44-9; quiz 75-6. PubMed ID: 14556603
    [TBL] [Abstract][Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.